bluebird bio Inc (BLUE)
1.015
+0.06
(+6.51%)
USD |
NASDAQ |
Apr 19, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Cash from Investing (TTM): 254.41M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 254.41M |
June 30, 2023 | 207.93M |
March 31, 2023 | 262.66M |
December 31, 2022 | 250.45M |
September 30, 2022 | 208.14M |
June 30, 2022 | 312.44M |
March 31, 2022 | 311.13M |
December 31, 2021 | 562.56M |
September 30, 2021 | 650.44M |
June 30, 2021 | -196.48M |
March 31, 2021 | 12.43M |
December 31, 2020 | -84.34M |
September 30, 2020 | -49.91M |
June 30, 2020 | 806.15M |
March 31, 2020 | 769.30M |
December 31, 2019 | 507.81M |
September 30, 2019 | -96.54M |
June 30, 2019 | -191.71M |
March 31, 2019 | -451.62M |
December 31, 2018 | -679.44M |
September 30, 2018 | -230.75M |
June 30, 2018 | -663.40M |
Date | Value |
---|---|
March 31, 2018 | -576.90M |
December 31, 2017 | -316.63M |
September 30, 2017 | -476.78M |
June 30, 2017 | -18.46M |
March 31, 2017 | -1.79M |
December 31, 2016 | 67.11M |
September 30, 2016 | -21.51M |
June 30, 2016 | -230.77M |
March 31, 2016 | -314.44M |
December 31, 2015 | -571.87M |
September 30, 2015 | -323.10M |
June 30, 2015 | -348.96M |
March 31, 2015 | -347.65M |
December 31, 2014 | -157.19M |
September 30, 2014 | -190.08M |
June 30, 2014 | -16.51M |
March 31, 2014 | -11.53M |
December 31, 2013 | -9.823M |
September 30, 2013 | -4.889M |
June 30, 2013 | -2.915M |
March 31, 2013 | -1.388M |
December 31, 2012 | 2.599M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-196.48M
Minimum
Jun 2021
806.15M
Maximum
Jun 2020
249.83M
Average
252.43M
Median
Cash from Investing (TTM) Benchmarks
Novavax Inc | -58.81M |
Motus GI Holdings Inc | -0.104M |
Tivic Health Systems Inc | -0.118M |
Vertex Pharmaceuticals Inc | -3.142B |
AIM ImmunoTech Inc | -0.832M |